Dr. Dr. Peter Metrakos, MD, Surgery

Claim this profile

Royal Victoria Hospital, McGill University Health Centre

Studies Postoperative Complications
Studies Insulin Resistance
5 reported clinical trials
8 drugs studied

Affiliated Hospitals

Image of trial facility.

Royal Victoria Hospital, McGill University Health Centre

Image of trial facility.

Royal Victoria Hospital

Clinical Trials Dr. Peter Metrakos, MD, Surgery is currently running

Image of trial facility.

High-Dose Insulin Therapy

for Liver Regeneration

The primary objective of this interventional study is determine if the future liver remnant can be optimized by improving liver function pre-operatively in patients who are scheduled for major hepatectomy. The main questions it aims to answer are: 1. Does high-dose insulin therapy improve liver function in the pre-operative setting? 2. What is the effect of high-dose insulin therapy on liver function and liver regeneration after a liver venous deprivation (LVD) procedure? 3. What is the relationship between volume hypertrophy and function in the regenerating liver? Participants will receive a 6-hour infusion of insulin and dextrose to maintain a hyperinsulinemic-normoglycemic state in the weeks prior to planned liver surgery to assess its effect on liver function measured by 99m-Tc-Mebrofenin hepatobiliary scintigraphy.

Recruiting

1 award

N/A

3 criteria

Image of trial facility.

High Dose Insulin

for Surgical Site Infections

Despite improvements in surgical techniques and perioperative care, the high incidence of postoperative surgical site infections remains a major problem in patients undergoing major abdominal surgery (liver, pancreatic and colorectal surgery). Using the hyperinsulinemic-normoglycemic clamp technique, i.e. continuous infusion of insulin combined with dextrose titrated to "clamp" blood glucose between 4 and 6 mmol/L, we successfully established and preserved normoglycemia during the perioperative period. Our objective of this study is to determine if the maintenance of perioperative normoglycemia by a hyperinsulinemic normoglycemic clamp reduces the rates of incisional and space/ surgical site infections following abdominal surgery (liver, pancreatic and colorectal surgery).

Recruiting

0 awards

N/A

More about Dr. Peter Metrakos, MD, Surgery

Clinical Trial Related

2 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical Trials

Treatments Dr. Peter Metrakos, MD, Surgery has experience with

  • Hyperinsulinemic Normoglycemic Clamp
  • Hyperinsulinemic Normoglycemic Clamp
  • Standard Glucose Management
  • Liver Resection
  • Preoperative Glucose Infusion
  • Preoperative Normal Saline Infusion

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Dr. Peter Metrakos, MD, Surgery specialize in?

Is Dr. Peter Metrakos, MD, Surgery currently recruiting for clinical trials?

Are there any treatments that Dr. Peter Metrakos, MD, Surgery has studied deeply?

What is the best way to schedule an appointment with Dr. Peter Metrakos, MD, Surgery?

What is the office address of Dr. Peter Metrakos, MD, Surgery?

Is there any support for travel costs?